COVID-19

I think it’s important that we recognize the impact COVID has had on our staff — and in some cases, recognize the damage it has done. Our staff are experiencing dissatisfaction and disconnection at...

Contrary to some clinical observations, aspirin and apixaban (Eliquis) do not reduce the rate of major adverse cardiovascular or pulmonary outcomes in stable outpatients with symptomatic COVID-19, researchers...

Rates have steadily fallen since an uptick in September, according to data submitted by facilities to the agency’s National Healthcare Safety Network.

High doses of the anticoagulant reduce the risk of developing the dangerous blood clots that are a hallmark of COVID-19, two new studies confirm.

Subgroup analysis suggests that poor oral health may increase severity of COVID-19 in patients with cardiovascular diseases

Age less than 40 years, nasal congestion at the time of COVID-19 infection positively associated with recovery of smell

In a unanimous vote, advisers agreed that vulnerable Moderna vaccine recipients should be offered a third shot. A half dose will be effective and will help protect against side effects, the drugmaker says.

If authorized for emergency use, certain patients could take molnupiravir at home after COVID-19 diagnosis, the drug’s developers said. 

Recovered COVID-19 patients may gain more protection from a booster shot when compared to their peers who haven’t caught the virus. Researchers say the findings could help determine ideal booster vaccine...

AHCA/NCAL’s first convention in two years featured speakers sharing personal tales from the pandemic’s darkest days and praise for the heroes who helped skilled nursing homes survive.